Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT06405152 · ClinicalTrials.gov registry record
Assessment of Macrophage Activation syndromE in STill's Disease
A clinical trial, sponsored by Swedish Orphan Biovitrum.
- Completed
- Registry status
- 75
- Enrollment target
NCT06405152: Completed study, sponsored by Swedish Orphan Biovitrum.
NCT06405152 is a clinical trial that has completed, run by Swedish Orphan Biovitrum. The registered enrollment target is 75 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT06405152 has completed, sponsored by Swedish Orphan Biovitrum.
- COMPLETED
- Registry status
- 75 participants
- Enrollment target
Study Summary
Assessment of Macrophage activation syndrome in STill's disease: retrospective chart analysis of patient History, Symptom resolution and Treatment characteristics
Primary Outcome
The proportion of patients alive after 1-year of follow-up
Interventions
- OTHER Chart review
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 75 participants |
| Start Date | 2023-09-27 |
| Est. Completion | 2024-09-26 |
What the finished NCT06405152 record still lists
NCT06405152 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 75 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Chart review is the first listed.
NCT06405152 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT06405152 about?
NCT06405152 is a clinical study titled "Assessment of Macrophage Activation syndromE in STill's Disease". Assessment of Macrophage activation syndrome in STill's disease: retrospective chart analysis of patient History, Symptom resolution and Treatment characteristics
What is the current status of trial NCT06405152?
This trial is currently completed. The enrollment target is 75 participants. The study started on 2023-09-27. Estimated completion is 2024-09-26.
What interventions are being tested in trial NCT06405152?
The interventions under investigation include: Chart review (OTHER).
Who is sponsoring clinical trial NCT06405152?
This trial is sponsored by Swedish Orphan Biovitrum, which has 23 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01535430 · 75 participants
Assessment of Eloquent Function in Brain Tumor Patients
- NCT01542879 · 75 participants · Phase 1
Development of Radiation Free Whole Body Magnetic Resonance (MR) Imaging Technique for Staging Children With Cancer
- NCT02232191 · 75 participants · Phase 2
Immunologic Response to Pneumococcal Polysaccharide Vaccine in Splenic Injury Patients
- NCT02754544 · 75 participants · NA
Electrocorticography in Mapping Functional Brain Areas During Surgery in Patients With Brain Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI